Clinical trial
Observational Retrospective Cohort Study in Patients With Relapsed Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated With Olaparib Following Response to Platinium-based Chemotherapy
NCT04152941 is registered in ClinicalTrials.gov with ARCAGY/ GINECO GROUP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Retrospective Cohort Study in Patients With Relapsed Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated With Olaparib Following Response to Platinium-based Chemotherapy
- Lead sponsor
- ARCAGY/ GINECO GROUP
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 11, 2018
- Completion date
- February 11, 2020
- Enrollment
- 130 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.
relapsed ovarian cancers patients